新西兰单剂水痘疫苗项目对住院及传染病不公平的影响:回顾性队列研究
新西兰2017年7月将免费单剂水痘疫苗纳入国家免疫规划。本研究回顾分析2007–2023年0–15岁儿童水痘相关住院,比较资助前(2007–2017)、过渡期(2018–2019)和资助后(2020–2023)的发病率与并发症。资助后水痘住院从每年368例降至94例(降74%),并发症降83%,1–4岁儿童获益最大(降88%),但 Māori 与太平洋儿童免疫覆盖不公平仍存。
要点
- 单剂水痘疫苗资助后,儿童水痘住院降74%,并发症降83%。
- 1–4岁儿童住院降88%,<1岁婴儿降76%,提示间接保护。
- Māori 与太平洋儿童住院显著下降,但免疫覆盖不公平仍存。
核心结论
- 国家免疫规划引入水痘疫苗显著减少儿童水痘住院及并发症。
- Māori 与太平洋儿童免疫覆盖不公平仍存,需提升 underserved 人群接种率。
研究设计与样本
- 回顾性队列研究,分析2007–2023年新西兰0–15岁儿童全国健康数据库水痘相关住院。
- 以ICD-10-AM出院编码识别首次水痘相关住院,比较资助前、过渡期和资助后三个时期。
主要发现
- 共4,946例水痘住院,资助后较资助前住院从每年368例降至94例(降74%)。
- 相关并发症降83%,主要由感染性并发症驱动。
- 首次水痘住院中位年龄2岁,73%首次入院为<5岁儿童。
- 1–4岁儿童住院降88%,<1岁婴儿降76%,提示疫苗间接保护。
- Māori 与太平洋儿童住院显著下降。
临床怎么用
- 维持并提升水痘疫苗接种覆盖,尤其针对 Māori 与太平洋等 underserved 人群。
- 关注<1岁婴儿的间接保护,推动高覆盖以维持群体免疫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In July 2017, a fully funded single-dose varicella vaccine was introduced to Aotearoa New Zealand's (NZ) National Immunization Schedule. This study assessed the vaccine's impact on hospitalizations, complications, and health disparities. METHODS: A retrospective cohort study was conducted, analyzing varicella-related hospitalizations between 2007 and 2023 for NZ children aged 0-15 years, using national health databases. First varicella-related hospitalizations were identified by ICD-10-AM discharge codes. Incidence rates and subsequent varicella-related complications were compared across varicella vaccine funding periods: before funding (2007-2017), transition (2018-2019), and after funding (2020-2023). FINDINGS: There were 4,946 varicella hospitalizations with a 74% reduction in varicella-related admissions after funding compared to before funding (from 368 to 94 admissions per year). Associated complications decreased by 83%, with infective complications driving this. The median age of first varicella-related hospitalization was 2 years, with 73% of first admissions in children under 5 years. Children aged 1-4 years showed the greatest benefit (88% reduction), followed by infants under 1 year (76%) indicating indirect vaccine protection. Māori and Pacific children experienced significant reductions. INTERPRETATION: The introduction of varicella vaccine on the National Immunization Schedule significantly reduced hospitalizations with varicella and its complications. However, health inequities in immunization coverage remain with Māori and Pacific children disproportionately affected. Efforts to increase vaccination coverage, particularly among underserved populations, are critical to sustaining and enhancing these gains.
引用
- Fay MJ, Howe AS, Wilson E, et al. Impact of a single-dose program on varicella hospitalizations and infectious disease inequity in New Zealand: A retrospective cohort study. Vaccine. 2025. PMID: 41354027. doi:10.1016/j.vaccine.2025.128082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。